title: Preclinical models for defining efficacy of drug combinations: mapping the road to the clinic.
authors.affiliation: Developmental Therapeutics Program, National Cancer Institute, NIH, Rockville, MD 20852, USA. mgitler@novaresearch.com
authors.forename: Miriam S
authors.initials: MS
authors.lastname: Gitler
authors.forename: Anne
authors.initials: A
authors.lastname: Monks
authors.forename: Edward A
authors.initials: EA
authors.lastname: Sausville
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D018929:Cell Culture Techniques; D004353:Drug Evaluation, Preclinical / Q000379:methods* / Q000592:standards; D004354:Drug Screening Assays, Antitumor / Q000379:methods; D006801:Humans; D008954:Models, Biological; D009369:Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents